Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (161-170 of 229) with videos related to

Pageof 23
Sort By:
Annals of Hepatology|February 12, 2015
Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosisYuan-Lung Cheng, Yuan-Chen Wang, Keng-Hsin Lan, et al.
Hepatology (Baltimore, Md.)|July 19, 2012
Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer systemChia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Journal of Gastroenterology and Hepatology|June 12, 2024
The association between proton-pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomyChun-Ting Ho, Chia-Chu Fu, Elise Chia-Hui Tan, et al.
Clinical and Molecular Hepatology|April 11, 2024
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinomaChun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, et al.
Alimentary Pharmacology & Therapeutics|March 14, 2023
Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomyWei-Yu Kao, Elise Chia-Hui Tan, Hsin-Lun Lee, et al.
American Journal of Cancer Research|August 6, 2021
Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAgI-Cheng Lee, Hao-Jan Lei, Gar-Yang Chau, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 4, 2021
(Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 PathwayYun-Cheng Hsieh, Kuei-Chuan Lee, Hao-Jan Lei, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 21, 2019
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resectionShih-Hao Young, Gar-Yang Chau, I-Cheng Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 25, 2017
Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinomaPei-Chang Lee, Yi-Tzen Chen, Yee Chao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2019
A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinomaI-Cheng Lee, Ya-Wen Hung, Chien-An Liu, et al.
Pageof 23

Showing results (161-170 of 229) with videos related to

Sort By:
Pageof 23
Annals of Hepatology|February 12, 2015
Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosisYuan-Lung Cheng, Yuan-Chen Wang, Keng-Hsin Lan, et al.
Hepatology (Baltimore, Md.)|July 19, 2012
Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer systemChia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Journal of Gastroenterology and Hepatology|June 12, 2024
The association between proton-pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomyChun-Ting Ho, Chia-Chu Fu, Elise Chia-Hui Tan, et al.
Clinical and Molecular Hepatology|April 11, 2024
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinomaChun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, et al.
Alimentary Pharmacology & Therapeutics|March 14, 2023
Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomyWei-Yu Kao, Elise Chia-Hui Tan, Hsin-Lun Lee, et al.
American Journal of Cancer Research|August 6, 2021
Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAgI-Cheng Lee, Hao-Jan Lei, Gar-Yang Chau, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 4, 2021
(Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 PathwayYun-Cheng Hsieh, Kuei-Chuan Lee, Hao-Jan Lei, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 21, 2019
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resectionShih-Hao Young, Gar-Yang Chau, I-Cheng Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 25, 2017
Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinomaPei-Chang Lee, Yi-Tzen Chen, Yee Chao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2019
A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinomaI-Cheng Lee, Ya-Wen Hung, Chien-An Liu, et al.
Pageof 23